About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Myh6-Ppara)402-2Dpk
transgene insertion 402-2, Daniel P Kelly
MGI:3641546
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
tg1
Tg(Myh6-Ppara)402-2Dpk/0 involves: C57BL/6 * CBA/J MGI:3652398


Genotype
MGI:3652398
tg1
Allelic
Composition
Tg(Myh6-Ppara)402-2Dpk/0
Genetic
Background
involves: C57BL/6 * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• exhibit neutral lipid droplet accumulation in cardiac myocytes after a short-term fast
• myocardial triacylglycerol levels are higher in fasted mutants than in controls, specifically long-chain fatty acid-containing triacylglycerol
• myocyte hypertrophy seen in 3-month old mutants
• exhibit an increase in biventricular weight/body weight ratio
• mean rate of [3H]palmitate oxidation is 64% higher in isolated hearts, indicating increased fatty acid utilization
• mean glucose oxidation rates are diminished by 63% in hearts, indicating decreased glucose utilization
• the posterior wall thickness is increased and fractional shortening is reduced
• exhibit signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and alteration systolic ventricular function

homeostasis/metabolism
• exhibit neutral lipid droplet accumulation in cardiac myocytes after a short-term fast
• myocardial triacylglycerol levels are higher in fasted mutants than in controls, specifically long-chain fatty acid-containing triacylglycerol

muscle
• exhibit neutral lipid droplet accumulation in cardiac myocytes after a short-term fast
• myocardial triacylglycerol levels are higher in fasted mutants than in controls, specifically long-chain fatty acid-containing triacylglycerol
• myocyte hypertrophy seen in 3-month old mutants
• the posterior wall thickness is increased and fractional shortening is reduced
• exhibit signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and alteration systolic ventricular function

growth/size/body
• exhibit an increase in biventricular weight/body weight ratio

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
diabetes mellitus DOID:9351 J:110580





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory